Clinical trial
Inhibition of Aortic Valve Calcification Through the Carboxylation Mechanism of Matrix Gla Protein (MGP), Following Administration of Vitamin K2 (Menaquinone-7). Correlation With Mitral Annulus and Ascending Aorta Calcification.
NCT04429035 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhibition of Aortic Valve Calcification Through the Carboxylation Mechanism of Matrix Gla Protein (MGP), Following Administration of Vitamin K2 (Menaquinone-7). Correlation With Mitral Annulus and Ascending Aorta Calcification.
- Lead sponsor
- National and Kapodistrian University of Athens
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 23, 2019
- Completion date
- December 23, 2023
- Enrollment
- 200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve calcification, aortic valve stenosis, mitral annular calcification, mitral valve calcification, mitral valve stenosis